DDR1-IN-1 is primarily used in biochemical research to study the role of discoidin domain receptor 1 (DDR1) in various cellular processes. It serves as a potent and selective inhibitor of DDR1, enabling researchers to investigate its involvement in cancer progression, fibrosis, and other diseases. By blocking DDR1 activity, this compound helps in understanding the receptor's signaling pathways and its impact on cell adhesion, migration, and proliferation. It is particularly valuable in preclinical studies aimed at developing targeted therapies for conditions where DDR1 overexpression or dysregulation is implicated. Additionally, DDR1-IN-1 is utilized in drug discovery efforts to identify potential therapeutic agents for treating DDR1-associated disorders.